The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forward.
As for a consolidated tradition, the 5th annual meeting of the Italian Network for Cancer Biotherapy took place in the Certosa of Pontignano, a Tuscan monastery, on September 20-22, 2007. The congress gathered more than 40 Italian leading groups representing academia, biotechnology and pharmaceutical industry. Aim of the meeting was to share new advances in cancer bio-immunotherapy and to promote their swift translation from pre-clinical research to clinical applications. Several topics were covered including: a) molecular and cellular mechanisms of tumor escape; b) therapeutic antibodies and recombinant constructs; c) clinical trials up-date and new programs; d) National Cooperative Networks and their potential interactions; e) old and new times in cancer immunology, an "amarcord". Here, we report the main issues discussed during the meeting.
Maio
Michele
M
Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. mmaio@cro.it
Nicolay
Hugues Jm
HJ
Ascierto
Paolo
P
Belardelli
Filippo
F
Camerini
Roberto
R
Colombo
Mario P
MP
Queirolo
Paola
P
Ridolfi
Ruggero
R
Russo
Vincenzo
V
Anzalone
Lucia
L
Fonsatti
Ester
E
Parmiani
Giorgio
G
D000818:Animals; D001691:Biological Therapy; D019496:Cancer Vaccines / Q000276:immunology; D003299:Cooperative Behavior; D044127:Epigenesis, Genetic; D006801:Humans; D007558:Italy; D051379:Mice; D009369:Neoplasms / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D019139:Tumor Escape / Q000276:immunology; D014611:Vaccination
D019496:Cancer Vaccines